Santa Cruz Biotechnology features a diverse variety of CD165 monoclonal antibodies for research focused on understanding this important protein. CD165 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD165, also known as the C-type lectin domain family 1 member A, plays a crucial role in immune response and cell signaling. CD165 is involved in the regulation of various biological processes, including cell adhesion, migration, and activation of immune cells. Understanding CD165 function is essential for elucidating its implications in immune-related diseases and potential therapeutic targets. CD165 monoclonal antibodies enable precise detection and characterization in diverse experimental settings. Researchers worldwide rely on CD165 monoclonal antibodies to advance their investigations of cellular pathways and mechanisms. Santa Cruz Biotechnology monoclonal antibodies for CD165 continue to support scientific discoveries that enhance our understanding of immune system regulation and disease mechanisms.